Regular Series Drug update From Nobel Prize to clinical practice: an update on messenger RNA-based therapies for lipid disorders MedicineToday July 2024 2024; 25(7): 32-37
Regular Series Cardiovascular medicine clinic Lipid-lowering therapy for older people: update on prescribing MedicineToday March 2024 2024; 25(3): 49-58
Regular Series Cardiovascular medicine clinic Lipid-lowering therapy for older people: the changing paradigm MedicineToday January/February 2024 2024; 25(1-2): 39-45
Regular Series Cardiovascular medicine clinic Ongoing challenges in lipid management – a retrospective in nine cases MedicineToday November 2023 2023; 24(11): 47-50
Feature Article Genetics Familial hypercholesterolaemia: improving the health of individuals and families Karen Birkenhead, Mitchell Sarkies, Samantha Sundercombe, Claire Trumble, Sanjyot Vagholkar, David R. Sullivan MedicineToday September 2023 2023; 24(9): 31-37
Feature Article Lipid disorders Familial hypercholesterolaemia – enhancing the care of patients and families MedicineToday 2023; 24(8 Suppl): 4-13
In Brief Familial hypercholesterolaemia cascade screening program shown to be cost effective MedicineToday June 2023
Feature Article Cardiovascular medicine Renal artery stenosis and hypertension: when to screen and how to treat MedicineToday March 2023 2023; 24(3): 23-29
Clinical Flowchart Cardiovascular medicine Duration of anticoagulation for VTE MedicineToday July 2022 2022; 23(7): 14-20
Feature Article Cardiovascular medicine Anticoagulation – extended treatment for venous thromboembolism MedicineToday July 2022 2022; 23(7): 14-20
Regular Series Clinical case review Side effects during cholesterol management. Is statin therapy always the cause? MedicineToday December 2021 2021; 22(12): 48-49
Regular Series ECG education An uncommon cause of a common condition CardiologyToday October 2021 2021; 11(2): 81-82
Feature Article Lipid disorders Lipid management – what counts, what is new? CardiologyToday October 2021 2021; 11(2): 66-70
Regular Series Drug update Two PCSK9 inhibitors now PBS-subsidised for cholesterol control MedicineToday September 2021 2021; 22(9): 59-60
Clinical Flowchart Cardiovascular medicine Suggested algorithm for cascade testing for familial hypercholesterolaemia MedicineToday July 2021 2021; 22(7): 10-20
Feature Article Cardiovascular medicine Genetic testing for familial hypercholesterolaemia: a test for the family MedicineToday July 2021 2021; 22(7): 10-20
Regular Series Cardiometabolism clinic Reducing cardiovascular risk in type 2 diabetes: emerging therapies MedicineToday Focus on cardiometabolic matters – 2020 2020; 21(11 Suppl): 26-28
Regular Series Drug update An update on lipid therapy with PCSK9 inhibitors Leon A. Simons MedicineToday June 2018 2018; 19(6): 57-59
Regular Series Perspectives Statin intolerance in people with diabetes: a clinical approach EndocrinologyToday May 2018 2018; 7(2): 34-36
Feature Article Lipid metabolism disorders Intensive lipid-modifying therapy: why, when, who and how? CardiologyToday July 2017 2017; 7(1): 11-14
Clinical Flowchart Endocrinology and metabolism An approach to initiating lipid-lowering therapy in patients with type 2 diabetes MedicineToday January 2017 2017; 18(1): 22-27
Feature Article Endocrinology and metabolism Managing lipid abnormalities in type 2 diabetes MedicineToday January 2017 2017; 18(1): 22-27
Regular Series Drug update Alirocumab and evolocumab: a new era in cholesterol control MedicineToday October 2016 2016; 17(10): 51-53
Regular Series Case studies Familial hypercholesterolaemia: detect in an individual, treat the extended family CardiologyToday March 2016 2016; 6(1): 31-33
Clinical Flowchart Genetics Suggested stratification and management allocation strategy for adults diagnosed with FH MedicineToday August 2015 2015; 16(8): 20-26
